New Approach to Affordable Care Act Waivers Causes Controversy
The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.
Preserving Clinician Discretion Under Health Privacy Regulation
HIPAA does not stop health care providers from disclosing patient information to provide better care.
Proposed Rule Aims to Make Drug Pricing More Transparent
A proposed requirement to display drug list prices in advertisements draws controversy.
Deregulatory Realities and Illusions
President Trump’s claims that deregulation has greatly helped the economy are exaggerated.
How to Better Regulate Payments to Research Participants
Experts say federal agencies must clarify rules permitting payment to research subjects.
Curbing Prescription Opioid Abuse Through Insurance Regulation
New study shows regulators have overlooked insurers in tackling the opioid epidemic.
The Constitutional Executive Order on Regulatory Budgets
President Trump’s regulation-trimming executive order will likely survive judicial scrutiny despite potential policy objections.
Regulating the “Kidney Club”
Scholar finds that many citizens are comfortable with providing financial incentives to living organ donors.
Encouraging Customization and Courtroom Claims in Long-term Care
Controversial rule promotes personal care and bars forced arbitration in long-term health care.
Successfully Protecting Public Insurance from Fraud
Health care fraud program reports billions of taxpayer dollars returned to federal health funds.
The Unhealthy Return to Individual Responsibility in Health Policy
The Republicans’ ACA replacement plan espouses individual responsibility—a naïve and ill-advised approach to healthcare reform.
President Obama Signs First Ever Sexual Assault Survivors’ Bill of Rights
The bill begins to close gaps in state-by-state regulatory treatment of sexual assault survivors.